Published in J Clin Virol on May 01, 2010
The short- and long-term risk of stroke after herpes zoster - a nationwide population-based cohort study. PLoS One (2013) 1.25
A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One (2011) 1.01
Herpes zoster vaccination. Korean J Pain (2013) 1.00
Productive vs non-productive infection by cell-free varicella zoster virus of human neurons derived from embryonic stem cells is dependent upon infectious viral dose. Virology (2013) 1.00
Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humans. J Immunol (2013) 0.97
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients. Blood (2014) 0.93
Healthcare-associated viral and bacterial infections in dentistry. J Oral Microbiol (2012) 0.93
Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 0.93
Disease burden of herpes zoster in Sweden--predominance in the elderly and in women - a register based study. BMC Infect Dis (2013) 0.92
Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models. J Neurovirol (2011) 0.91
The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma. Korean J Hematol (2010) 0.89
Increased risk of herpes zoster in children with asthma: a population-based case-control study. J Pediatr (2013) 0.88
A case of meningitis due to varicella zoster virus reactivation in an immunocompetent child. Ital J Pediatr (2013) 0.86
Toll-like receptor sensing of human herpesvirus infection. Front Cell Infect Microbiol (2012) 0.86
Compliance with infection control practices in an university hospital dental clinic. GMS Hyg Infect Control (2014) 0.84
Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan. BMC Cancer (2012) 0.83
Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): a phase-I, open-label study in Japanese adults. Hum Vaccin Immunother (2013) 0.82
Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: a randomized study of a single dose vs. two different two-dose schedules. Hum Vaccin Immunother (2013) 0.82
Asthma as a risk factor for zoster in adults: A population-based case-control study. J Allergy Clin Immunol (2015) 0.81
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. BMC Infect Dis (2017) 0.81
Evaluation of Chosen Cytokine Levels among Patients with Herpes Zoster as Ability to Provide Immune Response. PLoS One (2016) 0.81
Association between herpes zoster and end stage renal disease entrance in chronic kidney disease patients: a population-based cohort study. Eur J Clin Microbiol Infect Dis (2014) 0.80
Risk of herpes zoster in children with asthma. Allergy Asthma Proc (2015) 0.80
The burden of disease of Herpes Zoster in Tuscany. Hum Vaccin Immunother (2014) 0.80
Reducing the burden of Herpes Zoster in Italy. Hum Vaccin Immunother (2014) 0.79
Arsenic exposure and prevalence of the varicella zoster virus in the United States: NHANES (2003-2004 and 2009-2010). Environ Health Perspect (2015) 0.79
Varicella zoster virus-associated morbidity and mortality in Africa: a systematic review protocol. BMJ Open (2016) 0.78
Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge. J Virol (2014) 0.78
Animal models of varicella zoster virus infection. Pathogens (2013) 0.78
Is ultra-violet radiation the main force shaping molecular evolution of varicella-zoster virus? Virol J (2011) 0.78
Risk of Herpes Zoster and Family History: A Meta-analysis of Case-control Studies. Indian J Dermatol (2016) 0.78
Evaluation of efficacy and effectiveness of live attenuated zoster vaccine. J Prev Med Hyg (2014) 0.77
Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China. Hum Vaccin Immunother (2015) 0.77
Effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. J Am Pharm Assoc (2003) (2013) 0.76
Telomere length dynamics in human memory T cells specific for viruses causing acute or latent infections. Immun Ageing (2013) 0.76
Herpes zoster in a 6-month-old infant with 13-year follow-up: a retrospective case report. J Chiropr Med (2011) 0.75
PROTECTIVE LEVELS OF VARICELLA-ZOSTER ANTIBODY DID NOT EFFECTIVELY PREVENT CHICKENPOX IN AN X-LINKED AGAMMAGLOBULINEMIA PATIENT. Rev Inst Med Trop Sao Paulo (2015) 0.75
Mandibular osteonecrosis following herpes zoster infection in the mandibular branch of the trigeminal nerve: a case report and literature review. J Korean Assoc Oral Maxillofac Surg (2015) 0.75
Comparative preclinical evaluation of AS01 versus other Adjuvant Systems in a candidate herpes zoster glycoprotein E subunit vaccine. Hum Vaccin Immunother (2016) 0.75
Zoster duplex: a clinical report and etiologic analysis. Int J Clin Exp Med (2015) 0.75
Prevention of Herpes Zoster and its complications: from clinical evidence to real life experience. Hum Vaccin Immunother (2016) 0.75
Mitochondrial Haplogroups as a Risk Factor for Herpes Zoster. Open Forum Infect Dis (2016) 0.75
Incidence and risk factors of herpes zoster among adult renal transplant recipients receiving universal antiviral prophylaxis. BMC Infect Dis (2015) 0.75
Presentation and management of herpes zoster (shingles) in the geriatric population. P T (2013) 0.75
Safety and immunogenicity of a Herpes Zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously versus intramuscularly. Hum Vaccin Immunother (2016) 0.75
A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS One (2017) 0.75
A critical appraisal of 'Shingrix', a novel Herpes Zoster Subunit (HZ/Su or GSK1437173A) vaccine for Varicella Zoster Virus. Hum Vaccin Immunother (2017) 0.75
A rare case report and appraisal of the literature on spontaneous tooth exfoliation associated with trigeminal herpes zoster. Oral Maxillofac Surg (2016) 0.75
Bilateral herpes zoster in a patient with end-stage kidney disease. Int Med Case Rep J (2017) 0.75
A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc (2007) 5.13
What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect Dis (2004) 4.87
Postherpetic neuralgia--pathogenesis, treatment, and prevention. N Engl J Med (1996) 4.36
The incidence of herpes zoster. Arch Intern Med (1995) 3.87
Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid. J Immunol (1952) 3.83
Varicella-zoster virus in the saliva of patients with herpes zoster. J Infect Dis (2008) 3.52
The incidence of herpes zoster in a United States administrative database. J Gen Intern Med (2005) 3.31
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect (2001) 2.98
Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med (2002) 2.73
Immune responses to varicella-zoster in the aged. Arch Intern Med (1982) 2.59
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect (2008) 2.26
Racial differences in the occurrence of herpes zoster. J Infect Dis (1995) 2.14
Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol (2002) 2.05
Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel. Infection (2008) 1.92
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol (2002) 1.87
The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine (2001) 1.72
Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis (2008) 1.70
Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states. J Acquir Immune Defic Syndr (2005) 1.64
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J Virol (2006) 1.49
Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model. J Virol (2005) 1.48
Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma. J Clin Invest (1980) 1.48
The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am (1996) 1.41
A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J Infect Dis (2008) 1.30
Varicella-zoster virus immune evasion. Immunol Rev (1999) 1.25
Family history as a risk factor for herpes zoster: a case-control study. Arch Dermatol (2008) 1.24
Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol (2007) 1.24
Race and stress in the incidence of herpes zoster in older adults. J Am Geriatr Soc (1998) 1.22
Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient. N Engl J Med (1984) 1.19
Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis (1998) 1.16
Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc (1990) 1.16
Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv Virus Res (1996) 1.10
Varicella-zoster virus latency in human ganglia. Rev Med Virol (2002) 1.04
A review of the varicella vaccine in immunocompromised individuals. Int J Infect Dis (2004) 1.02
Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual. Clin Infect Dis (2006) 0.95
Severe complications of herpes zoster. Herpes (2007) 0.94
Polymorphism of the IL-10 gene is associated with susceptibility to herpes zoster. Scand J Infect Dis (2002) 0.92
Managing ophthalmic herpes zoster in primary care. BMJ (2005) 0.92
The human histocompatibility leukocyte antigen (HLA) haplotype is associated with the onset of postherpetic neuralgia after herpes zoster. Pain (2004) 0.92
Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster. J Infect Dis (2007) 0.91
A case of varicella caused by co-infection with two different genotypes of varicella-zoster virus. J Clin Virol (2008) 0.91
Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccine. Curr Opin Pediatr (2004) 0.86
Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients. J Clin Microbiol (2006) 0.85
Immune evasion mechanisms of varicella-zoster virus. Arch Virol Suppl (2001) 0.83
Connection between varicella and herpes zoster. J Med (1986) 0.79
Recommendations for the management of herpes zoster. Clin Infect Dis (2007) 4.33
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med (2015) 4.23
Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology (2010) 4.18
Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology (2004) 4.04
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis (2012) 3.94
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med (2015) 3.75
Genetic content of wild-type human cytomegalovirus. J Gen Virol (2004) 3.58
Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med (2012) 2.77
Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial. Ann Intern Med (2010) 2.73
Transmission of integrated human herpesvirus 6 through stem cell transplantation: implications for laboratory diagnosis. J Infect Dis (2006) 2.69
Validation of a 3-factor scoring model for the Pittsburgh sleep quality index in older adults. Sleep (2006) 2.62
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. Clin Infect Dis (2012) 2.55
Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet (2004) 2.54
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years. Hum Vaccin (2009) 2.51
Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics (2010) 2.45
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32
Essential roles of enteric neuronal serotonin in gastrointestinal motility and the development/survival of enteric dopaminergic neurons. J Neurosci (2011) 2.21
5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci (2009) 2.21
Dural arteriovenous fistulae: noninvasive diagnosis with dynamic MR digital subtraction angiography. AJNR Am J Neuroradiol (2002) 2.18
Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain (2004) 2.15
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis (2009) 2.13
The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother (2012) 2.11
Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. Pain (2015) 2.11
The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain (2007) 2.08
Central neuropathic itch from spinal-cord cavernous hemangioma: a human case, a possible animal model, and hypotheses about pathogenesis. Pain (2005) 2.02
Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine (2007) 2.01
Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis (2012) 1.98
Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev (2003) 1.95
Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy. J Clin Oncol (2009) 1.92
PEPtalk: postexposure prophylaxis against varicella in children with cancer. Arch Dis Child (2011) 1.91
Herpes zoster. BMJ (2007) 1.91
Long-lived intestinal tuft cells serve as colon cancer-initiating cells. J Clin Invest (2014) 1.90
The tryptophan hydroxylase inhibitor LX1031 shows clinical benefit in patients with nonconstipating irritable bowel syndrome. Gastroenterology (2011) 1.88
The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ (2010) 1.88
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol (2002) 1.87
Two novel spliced genes in human cytomegalovirus. J Gen Virol (2003) 1.87
Congenital insensitivity to pain: an update. Pain (2003) 1.82
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2014) 1.81
Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2003) 1.78
Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS One (2011) 1.78
Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults. J Am Geriatr Soc (2010) 1.76
Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain (2002) 1.75
Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci U S A (2006) 1.75
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years. Hum Vaccin (2011) 1.73
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis (2007) 1.71
Vaccination against Herpes Zoster and Postherpetic Neuralgia. J Infect Dis (2008) 1.70
Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine. Gut (2013) 1.69
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2013) 1.69
Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer. J Invest Dermatol (2002) 1.66
Varicella vaccination in Europe - taking the practical approach. BMC Med (2009) 1.63
Mutations in microcephalin cause aberrant regulation of chromosome condensation. Am J Hum Genet (2004) 1.62
The burden of Herpes Zoster: a prospective population based study. Vaccine (2005) 1.61
The prevention and management of herpes zoster. Med J Aust (2008) 1.60
The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J Infect Dis (2002) 1.58
Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain (2003) 1.57
Dermatomal scratching after intramedullary quisqualate injection: correlation with cutaneous denervation. J Pain (2008) 1.57
A study of shingles and the development of postherpetic neuralgia in East London. J Med Virol (2003) 1.55
Human herpesvirus 6: relevance of infection in the immunocompromised host. Br J Haematol (2003) 1.48
Gastrointestinal neuromuscular pathology: guidelines for histological techniques and reporting on behalf of the Gastro 2009 International Working Group. Acta Neuropathol (2009) 1.48
The relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adults. Influenza Other Respir Viruses (2010) 1.47
Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18-45 years. Hum Vaccin (2011) 1.46
Mannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zoster. Cell (2004) 1.45
Hepatitis C prevalence in children with perinatal human immunodeficiency virus infection enrolled in a long-term follow-up protocol. Arch Pediatr Adolesc Med (2004) 1.44
Short-term changes in cerebral microhemodynamics after carotid stenting. AJNR Am J Neuroradiol (2003) 1.43
A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses. J Med Virol (2009) 1.42
Sequences of complete human cytomegalovirus genomes from infected cell cultures and clinical specimens. J Gen Virol (2009) 1.39
Widespread effects of clinically unilateral focal nerve injuries. Pain (2017) 1.39
Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J Invest Dermatol (2005) 1.38
Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry (2008) 1.38
Filter-protected versus unprotected carotid artery stenting: a randomised trial. Cerebrovasc Dis (2010) 1.38
Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain (2008) 1.38
The prevalence of chromosomally integrated human herpesvirus 6 genomes in the blood of UK blood donors. J Med Virol (2007) 1.37
Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet (2010) 1.36
Netrins and DCC in the guidance of migrating neural crest-derived cells in the developing bowel and pancreas. Dev Biol (2003) 1.36
Latent and lytic infection of isolated guinea pig enteric ganglia by varicella zoster virus. J Med Virol (2003) 1.34
Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J Infect Dis (2002) 1.33
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J (2006) 1.32
Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol (2008) 1.31
A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons. J Infect Dis (2008) 1.30
Neuronal serotonin regulates growth of the intestinal mucosa in mice. Gastroenterology (2012) 1.29
Dynamic radial projection MRI of inhaled hyperpolarized 3He gas. Magn Reson Med (2003) 1.28
Varicella zoster virus (VZV) infects and establishes latency in enteric neurons. J Neurovirol (2011) 1.28
Hand2 determines the noradrenergic phenotype in the mouse sympathetic nervous system. Dev Biol (2007) 1.26
Important role of mucosal serotonin in colonic propulsion and peristaltic reflexes: in vitro analyses in mice lacking tryptophan hydroxylase 1. J Physiol (2013) 1.25
Bone morphogenetic protein-2 and -4 limit the number of enteric neurons but promote development of a TrkC-expressing neurotrophin-3-dependent subset. J Neurosci (2004) 1.25
MRI assessment of basal ganglia iron deposition in Parkinson's disease. J Magn Reson Imaging (2008) 1.23
A prospective study of the herpes zoster severity of illness. Clin J Pain (2010) 1.22
Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. J Clin Microbiol (2006) 1.20
Bone morphogenetic protein regulation of enteric neuronal phenotypic diversity: relationship to timing of cell cycle exit. J Comp Neurol (2008) 1.20
Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J Infect Dis (2004) 1.19
Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Toll-like receptor 2. J Virol (2005) 1.19
VZV T cell-mediated immunity. Curr Top Microbiol Immunol (2010) 1.17
Magnetic resonance imaging and developmental outcome following preterm birth: review of current evidence. Dev Med Child Neurol (2008) 1.17
Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses. J Infect Dis (2010) 1.14
Expression and function of 5-HT4 receptors in the mouse enteric nervous system. Am J Physiol Gastrointest Liver Physiol (2005) 1.14
Homology between the human cytomegalovirus RL11 gene family and human adenovirus E3 genes. J Gen Virol (2003) 1.13